Kyungbo Pharmaceutical, 8.87% ↑ Amid Rising Theme of COVID-19 (Nafamostat)

On the 22nd, the COVID-19 (Nafamostat) theme rose by 3.72% compared to the previous day, showing strength, while Kyungbo Pharmaceutical, which is attracting attention as a related stock, surged by 8.87% compared to the previous day. Kyungbo Pharmaceutical is known as a manufacturer and seller of pharmaceutical raw materials.

[Graph] Major stock price changes in the COVID-19 (Nafamostat) theme

According to the analysis by Thinkpool Robo Algorithm RASSI, Kyungbo Pharmaceutical ranked 5th out of 13 stocks in the quant financial ranking by exceeding the theme's average scores in growth, stability, and profitability. This can be interpreted as Kyungbo Pharmaceutical having a relatively high investment attractiveness compared to other stocks within the theme from a financial perspective.

[Table] Top stocks by financial scores within the theme

※ The quant financial score is the result of the Robo Algorithm's analysis based on each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, and other factors.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.